Covid treatment: DRDO invites bids to transfer technology of 2-DG drug : vimarsana.com

Requirements for the bidders include a drug license to manufacture Active Pharmaceutical Ingredient (API) from Drug Licensing Authorities and WHO GMP (Good Manufacturing Practices) certification

Related Keywords

, Active Pharmaceutical Ingredient , Drug Licensing Authorities , Good Manufacturing Practices , 2dg Production , 2 Dg Production , 2dg Availability , 2 Dg , Covid Treatment Drug , Covid Treatment News , Covid Treatment List , Covid Treatment , India Covid News , Covid Latest News , Covid Update , Drdo , Drdo Covid Drug , செயலில் மருந்து மூலப்பொருள் , நல்ல உற்பத்தி ப்ர்யாக்டிஸஸ் , திர்தோ ,